Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer
-
Narrado por:
-
De:
Emeritus Professor Ian Frazer
University of Queensland
The future of cancer and medical research
In this episode, RCA Chief Executive Richard Vines speaks to Professor Ian Frazer about:
- Inventing the technology behind the world’s first cancer vaccine
- Vaccine hesitancy, and the potential of other vaccines for cancer
- What makes the Translational Research Institute so special
- The interface between clinicians, scientists and patients in medical research
- Our expanding understanding of cancer and targeted treatment
- The experience of being Australian of The Year, and what he’s working on now
- How the Medical Research Future Fund works
- The alleged brain drain of medical researchers from Australia
- The need to better embed medical research into the health system
- How he sees medical research benefiting patients in 10 years’ time
More about Emeritus Professor Ian Frazer
Ian and his colleague co-invented the technology behind the world’s first cervical cancer vaccine.
He is the founding CEO of the Translational Research Institute in Brisbane, heads a biotechnology company working on new vaccine technologies, and chairs the advisory board of the Medical Research Future Fund.
Todavía no hay opiniones